4//SEC Filing
Ciechanover Isaac E. 4
Accession 0001209191-19-024482
CIK 0001604464other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:19 PM ET
Size
8.2 KB
Accession
0001209191-19-024482
Insider Transaction Report
Form 4
Ciechanover Isaac E.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2019-04-10$37.04/sh−3,900$144,456→ 316,037 total(indirect: See footnote) - Sale
Common Stock
2019-04-11$36.27/sh−3,900$141,453→ 312,137 total(indirect: See footnote)
Holdings
- 332,243
Common Stock
Footnotes (4)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted January 23, 2018.
- [F2]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $36.74 to $37.48. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Shares are held by the Isaac E. Ciechanover and Allison M. Ciechanover Family Trust dated 8/8/08, of which the Reporting Person is a trustee.
- [F4]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $36.00 to $36.64. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001612096
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:19 PM ET
- Size
- 8.2 KB